Biolase PE Ratio 2010-2023 | BIOL
Current and historical p/e ratio for Biolase (BIOL) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biolase PE ratio as of April 24, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Biolase PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-04-25 |
0.15 |
|
0.00 |
| 2023-12-31 |
1.12 |
$-32.58 |
0.00 |
| 2023-09-30 |
1.86 |
$-158.82 |
0.00 |
| 2023-06-30 |
7.07 |
$-264.93 |
0.00 |
| 2023-03-31 |
28.12 |
$-347.00 |
0.00 |
| 2022-12-31 |
65.00 |
$-410.00 |
0.00 |
| 2022-09-30 |
243.00 |
$-357.00 |
0.00 |
| 2022-06-30 |
458.00 |
$-297.00 |
0.00 |
| 2022-03-31 |
883.00 |
$-206.00 |
0.00 |
| 2021-12-31 |
975.00 |
$-275.00 |
0.00 |
| 2021-09-30 |
1598.25 |
$-375.00 |
0.00 |
| 2021-06-30 |
1745.25 |
$-850.00 |
0.00 |
| 2021-03-31 |
2107.25 |
$-1,150.00 |
0.00 |
| 2020-12-31 |
1041.75 |
$-1,475.00 |
0.00 |
| 2020-09-30 |
687.75 |
$-1,625.00 |
0.00 |
| 2020-06-30 |
1157.50 |
$-1,725.00 |
0.00 |
| 2020-03-31 |
937.50 |
$-1,875.00 |
0.00 |
| 2019-12-31 |
1381.75 |
$-1,975.00 |
0.00 |
| 2019-09-30 |
2350.00 |
$-2,475.00 |
0.00 |
| 2019-06-30 |
3675.00 |
$-2,425.00 |
0.00 |
| 2019-03-31 |
5950.00 |
$-2,575.00 |
0.00 |
| 2018-12-31 |
2475.00 |
$-2,625.00 |
0.00 |
| 2018-09-30 |
5175.00 |
$-2,425.00 |
0.00 |
| 2018-06-30 |
3025.00 |
$-2,600.00 |
0.00 |
| 2018-03-31 |
5075.00 |
$-3,500.00 |
0.00 |
| 2017-12-31 |
5330.00 |
$-3,625.00 |
0.00 |
| 2017-09-30 |
7535.00 |
$-3,875.00 |
0.00 |
| 2017-06-30 |
12125.00 |
$-4,000.00 |
0.00 |
| 2017-03-31 |
16875.00 |
$-3,250.00 |
0.00 |
| 2016-12-31 |
17500.00 |
$-3,375.00 |
0.00 |
| 2016-09-30 |
21875.00 |
$-3,125.00 |
0.00 |
| 2016-06-30 |
14625.00 |
$-3,375.00 |
0.00 |
| 2016-03-31 |
16375.00 |
$-4,125.00 |
0.00 |
| 2015-12-31 |
10513.75 |
$-4,375.00 |
0.00 |
| 2015-09-30 |
11250.00 |
$-4,750.00 |
0.00 |
| 2015-06-30 |
21750.00 |
$-4,625.00 |
0.00 |
| 2015-03-31 |
25250.00 |
$-5,250.00 |
0.00 |
| 2014-12-31 |
32875.00 |
$-5,750.00 |
0.00 |
| 2014-09-30 |
31125.00 |
$-5,496.27 |
0.00 |
| 2014-06-30 |
27500.00 |
$-6,105.14 |
0.00 |
| 2014-03-31 |
30125.00 |
$-4,965.29 |
0.00 |
| 2013-12-31 |
35199.01 |
$-4,320.54 |
0.00 |
| 2013-09-30 |
23662.78 |
$-3,208.50 |
0.00 |
| 2013-06-30 |
44085.42 |
$-1,842.26 |
0.00 |
| 2013-03-31 |
48767.33 |
$-1,581.38 |
0.00 |
| 2012-12-31 |
22555.46 |
$-1,201.69 |
0.00 |
| 2012-09-30 |
20623.52 |
$-2,284.53 |
0.00 |
| 2012-06-30 |
23538.70 |
$-2,396.89 |
0.00 |
| 2012-03-31 |
32550.01 |
$-2,024.10 |
0.00 |
| 2011-12-31 |
30714.89 |
$-1,771.54 |
0.00 |
| 2011-09-30 |
35498.97 |
$-938.46 |
0.00 |
| 2011-06-30 |
60219.38 |
$-1,846.82 |
0.00 |
| 2011-03-31 |
56491.19 |
$-3,447.79 |
0.00 |
| 2010-12-31 |
20098.72 |
$-5,626.49 |
0.00 |
| 2010-09-30 |
13437.43 |
$-6,431.58 |
0.00 |
| 2010-06-30 |
17342.33 |
$-4,708.84 |
0.00 |
| 2010-03-31 |
22395.72 |
$-1,607.90 |
0.00 |
| 2009-12-31 |
21936.32 |
$-1,263.35 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
